Anthropic has launched Claude Science, an app that it says integrates the tools and packages that researchers most commonly use, produces auditable artifacts, and provides flexible access to computing resources. 

At the launch event, the company also announced that it will be using the product to pursue some of its own research into drugs for rare, neglected diseases. 

The company’s announcement said that Claude Science brings fragmented tools into a single research environment. It stated: “It helps you analyse literature and execute multi-step research, produces detailed artifacts, and lets you iteratively refine figures and manuscripts until they’re ready for publication. Every output carries an auditable history of how it was made, so you can validate and reproduce the results. Like a Jupyter Notebook, you can access Claude Science wherever you already work – locally on macOS or Linux, or on a remote machine over SSH or with an HPC login node.” 

Users will interact with a generalist coordinating agent with access to over 60 curated skills and connectors pre-configured for genomics, single-cell, proteomics, structural biology, cheminformatics, and more. These agents can spin up others and engage with specialist agents created by users, while a reviewer agent checks citations and calculations, flagging and correcting errors. 

The company will be supporting up to 50 Claude Science AI for Science projects, providing up to $30,000 in credits, while Modal will also be providing up to $2,000 in compute for select projects. It is looking for projects that span domains and “explore the boundaries of science”, with an early focus on biology and biomedical research. Applications are open until 15 July 2026, with award notifications sent out by 31 July.